Skip to main content

Table 3 Baseline characteristics, lipid profiles and gensini scores in coronary heart disease patients stratified by chronic kidney disease categories

From: Effect of renal function on high-density lipoprotein particles in patients with coronary heart disease

 

Normal Kidney Function (n = 192)

eGFR (ml/min·1.73 m2)

P value

60–90 (n = 160)

 ≤ 60 (n = 67)

eGFR (ml/min·1.73 m2)

106.30 ± 17.00ab

74.74 ± 8.88ac

50.26 ± 8.76bc

0.000

Sex(Male/Female)

138/54

135/25

55/12

0.013

Age

57.72 ± 9.70b

58.66 ± 12.36bc

62.17 ± 10.64bc

0.026

CR (чmol/L)

71.93 ± 11.42ab

93.30 ± 14.56ac

136.82 ± 46.97bc

0.000

TG (mmol/L)

1.82 ± 0.08

1.78 ± 0.08

1.73 ± 0.13

0.832

TC (mmol/L)

4.51 ± 0.09

4.74 ± 0.10

4.65 ± 0.12

0.175

HDL-C (mmol/L)

0.93 ± 0.02a

0.96 ± 0.02a

1.03 ± 0.03

0.014

LDL-C (mmol/L)

2.86 ± 0.07

3.03 ± 0.07

2.91 ± 0.10

0.203

apoA-I (g/L)

1.11 ± 0.01ab

1.13 ± 0.01ac

1.11 ± 0.02bc

0.713

apoB (g/L)

1.15 ± 0.22

0.99 ± 0.02

0.95 ± 0.03

0.679

Lp(a) (g/L)

0.29 ± 0.02ab

0.33 ± 0.03ac

0.33 ± 0.04bc

0.367

apoE (mg/L)

47.01 ± 1.24

46.33 ± 1.24

46.28 ± 1.93

0.910

HDL-C/apoA-I

0.83 ± 0.13b

0.85 ± 0.11c

0.90 ± 0.13bc

0.000

Gensini Scores

56.40 ± 3.11b

57.74 ± 3.49c

62.40 ± 6.34bc

0.644

  1. Aindicatesa significant difference between patients with normal kidney function and patients with mildly reduced kidney function (60 ml/min·1.73 m2eGFR < 90 ml/min·1.73 m2); b indicatesa significant difference between patients with normal kidney function and patients with moderately reduced kidney function (eGFR60 ml/min·1.73 m2); c indicates a significantdifference between patients with mildly reduced kidney function and patients with moderately reduced kidney function